Tag: Schedule 1

5
Apr

SSDP’s Federal Policy Agenda for the 117th Congress Has Been Released

Last month, SSDP’s U.S. Policy Council completed our Federal Policy Agenda for the 117th Congress. Written by SSDP members, alumni, and supporters, this document shows federal representatives and administrators our roadmap for fighting the War on Drugs and promoting sensible drug policy over the next 2 years. The agenda consists of six main sections, covering various community interests as they

Read more

24
Sep

Today Marks the 50th Anniversary of the Controlled Substances Act

Written by Abhi Dewan ‘18, U.S. Federal Policy Liaison 50 years ago today, the House of Representatives voted to list marijuana as a Schedule I controlled substance, escalating the war on marijuana. Last week, the House was poised to remedy injustice for those impacted, but instead chose to postpone their scheduled vote on the MORE Act. Though the bill was

Read more

29
Sep

An FGCU Student’s Reaction to the DEA Scheduling of Mitragyna Speciosa

Once again, the DEA has made a decision that will likely lead to more harm than good. The move to regulate Mitragyna speciosa (kratom) and its active alkaloids, mitragynine (MG) and 7-hydroxymitragynine (7HMG), as Schedule I substances is just one addition to a long list of poor policy decisions with little basis in science. Schedule I drugs are defined as

Read more

9
Aug

MDMA Still Harshly Restricted, Despite Medical Benefits

This blog post originally appeared at http://the-libertarian.co.uk. It is perhaps common knowledge that marijuana, though not legally available for recreational use, is now widely used for medical purposes. Twenty US states have signed effective medical marijuana measures into law, as well as the District of Columbia, along with a variety of other nations including Canada, Austria and the Czech Republic. The

Read more

19
Jun

Prohibition: Maybe It Will Work This Time?

              Today, the Drug Enforcement Administration published this press release commending Congress on passing an amendment to the the Food and Drug Administration Safety and Innovation Act that bans a host of chemical compounds. I wouldn’t exactly call it innovative, but rather more of the same failed ideology that we have come to expect

Read more